|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan D, Zhang X, Chen X, Mou Z, Hu J, Zhou
S, Ding J and Wu K: Bird's-eye view on gastric cancer research of
the past 25 years. J Gastroenterol Hepatol. 20:360–365. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu L, Zhou D, Jiang X, Song K, Li K and
Ding W: Loss of E-cadherin in multidrug resistant breast cancer
cell line MCF-7/Adr: Possible implication in the enhanced invasive
ability. Eur Rev Med Pharmacol Sci. 16:1271–1279. 2012.PubMed/NCBI
|
|
4
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J,
Jiang B, Shu Y and Liu P: miR-200bc/429 cluster modulates multidrug
resistance of human cancer cell lines by targeting BCL2 and XIAP.
Cancer Chemother Pharmacol. 69:723–731. 2012. View Article : Google Scholar
|
|
6
|
Cao W, Wei W, Zhan Z, Xie Y and Xiao Q:
miR-1284 modulates multidrug resistance of gastric cancer cells by
targeting EIF4A1. Oncol Rep. 35:2583–2591. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rawlings-Goss RA, Campbell MC and Tishkoff
SA: Global population-specific variation in miRNA associated with
cancer risk and clinical biomarkers. BMC Med Genomics. 7:532014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao WL, Wei WY, Zhan ZX, Xie DY, Xie YB
and Xiao Q: The role of miR-647 in human gastric cancer
suppression. Oncol Rep. 37:1401–1411. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim YW, Kim EY, Jeon D, Liu JL, Kim HS,
Choi JW and Ahn WS: Differential microRNA expression signatures and
cell type-specific association with Taxol resistance in ovarian
cancer cells. Drug Des Devel Ther. 8:293–314. 2014.
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
11
|
An Y, Zhang Z, Shang Y, Jiang X, Dong J,
Yu P, Nie Y and Zhao Q: miR-23b 3p regulates the chemoresistance of
gastric cancer cells by targeting ATG12 and HMGB2. Cell Death Dis.
6:e17662015. View Article : Google Scholar
|
|
12
|
Gisel A, Valvano M, El Idrissi IG,
Nardulli P, Azzariti A, Carrieri A, Contino M and Colabufo NA:
miRNAs for the detection of multidrug resistance: Overview and
perspectives. Molecules. 19:5611–5623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pérez-Tomás R: Multidrug resistance:
Retrospect and prospects in anti-cancer drug treatment. Curr Med
Chem. 13:1859–1876. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nishida T, Egashira Y, Akutagawa H, Fujii
M, Uchiyama K, Shibayama Y and Hirose Y: Predictors of lymph node
metastasis in T1 colorectal carcinoma: An immunophenotypic analysis
of 265 patients. Dis Colon Rectum. 57:905–915. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Díaz-López A, Moreno-Bueno G and Cano A:
Role of microRNA in epithelial to mesenchymal transition and
metastasis and clinical perspectives. Cancer Manag Res. 6:205–216.
2014.PubMed/NCBI
|
|
16
|
Sui H, Cai GX, Pan SF, Deng WL, Wang YW,
Chen ZS, Cai SJ, Zhu HR and Li Q: miR200c attenuates P-gp-mediated
MDR and metastasis by targeting JNK2/c-Jun signaling pathway in
colorectal cancer. Mol Cancer Ther. 13:3137–3151. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lambert S and Bennett V: Postmitotic
expression of ankyrinR and beta R-spectrin in discrete neuronal
populations of the rat brain. J Neurosci. 13:3725–3735.
1993.PubMed/NCBI
|
|
18
|
De Matteis MA and Morrow JS: The role of
ankyrin and spectrin in membrane transport and domain formation.
Curr Opin Cell Biol. 10:542–549. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu D and Bourguignon LY: Interaction
between CD44 and the repeat domain of ankyrin promotes hyaluronic
acid-mediated ovarian tumor cell migration. J Cell Physiol.
183:182–195. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bourguignon LY, Zhu H, Shao L and Chen YW:
Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic
breast tumor cell invasion and migration. J Cell Biol. 150:177–191.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu D and Bourguignon LY: The
ankyrin-binding domain of CD44s is involved in regulating
hyaluronic acid-mediated functions and prostate tumor cell
transformation. Cell Motil Cytoskeleton. 39:209–222. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Löhr M and Jesnowski R: Inhibition
of ankyrin-B expression reduces growth and invasion of human
pancreatic ductal adenocarcinoma. Pancreatology. 10:586–596. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Savas S, Azorsa DO, Jarjanazi H,
Ibrahim-Zada I, Gonzales IM, Arora S, Henderson MC, Choi YH,
Briollais L, Ozcelik H, et al: NCI60 cancer cell line panel data
and RNAi analysis help identify EAF2 as a modulator of simvastatin
and lovastatin response in HCT-116 cells. PLoS One. 6:e183062011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lokeshwar VB, Fregien N and Bourguignon
LY: Ankyrin-binding domain of CD44(GP85) is required for the
expression of hyaluronic acid-mediated adhesion function. J Cell
Biol. 126:1099–1109. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang W, Zhang Y, Kane KT, Collins MA,
Simeone DM, di Magliano MP and Nguyen KT: CD44 regulates pancreatic
cancer invasion through MT1-MMP. Mol Cancer Res. 13:9–15. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miletti-González KE, Chen S, Muthukumaran
N, Saglimbeni GN, Wu X, Yang J, Apolito K, Shih WJ, Hait WN and
Rodríguez-Rodríguez L: The CD44 receptor interacts with
P-glycoprotein to promote cell migration and invasion in cancer.
Cancer Res. 65:6660–6667. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang X, Iyer AK, Singh A, Choy E, Hornicek
FJ, Amiji MM and Duan Z: MDR1 siRNA loaded hyaluronic acid-based
CD44 targeted nanoparticle systems circumvent paclitaxel resistance
in ovarian cancer. Sci Rep. 5:85092015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nieh S, Jao SW, Yang CY, Lin YS, Tseng YH,
Liu CL, Lee TY, Liu TY, Chu YH and Chen SF: Regulation of tumor
progression via the Snail-RKIP signaling pathway by nicotine
exposure in head and neck squamous cell carcinoma. Head Neck.
37:1712–1721. 2015. View Article : Google Scholar
|
|
29
|
Sein TT, Thant AA, Hiraiwa Y, Amin AR,
Sohara Y, Liu Y, Matsuda S, Yamamoto T and Hamaguchi M: A role for
FAK in the Concanavalin A-dependent secretion of matrix
metalloproteinase-2 and -9. Oncogene. 19:5539–5542. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
You T, Gao W, Wei J, Jin X, Zhao Z, Wang C
and Li Y: Overexpression of LIMK1 promotes tumor growth and
metastasis in gastric cancer. Biomed Pharmacother. 69:96–101. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu L, Tanimoto A, Murata Y, Sasaguri T,
Fan J, Sasaguri Y and Watanabe T: Matrix metalloproteinase-12 gene
expression in human vascular smooth muscle cells. Genes Cells.
8:225–234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie S, Issa R, Sukkar MB, Oltmanns U,
Bhavsar PK, Papi A, Caramori G, Adcock I and Chung KF: Induction
and regulation of matrix metalloproteinase-12 in human airway
smooth muscle cells. Respir Res. 6:1482005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang B, Xu YF, He BS, Pan YQ, Zhang LR,
Zhu C, Qu LL and Wang SK: RNAi-mediated silencing of CD147 inhibits
tumor cell proliferation, invasion and increases chemosensitivity
to cisplatin in SGC7901 cells in vitro. J Exp Clin Cancer Res.
29:612010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lv FZ, Wang JL, Wu Y, Chen HF and Shen XY:
Knockdown of MMP12 inhibits the growth and invasion of lung
adenocarcinoma cells. Int J Immunopathol Pharmacol. 28:77–84. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
O'Shaughnessy J: Extending survival with
chemotherapy in metastatic breast cancer. Oncologist. 10(Suppl 3):
20–29. 2005. View Article : Google Scholar : PubMed/NCBI
|
